BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2165928)

  • 41. Interaction of hamster submaxillary sialyl-Tn and Tn glycoproteins with Gal, GalNAc and GlcNAc specific lectins.
    Wu AM; Shen F; Herp A; Wu JH
    Mol Immunol; 1994 Apr; 31(6):485-90. PubMed ID: 8183285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.
    Kuzmanov U; Musrap N; Kosanam H; Smith CR; Batruch I; Dimitromanolakis A; Diamandis EP
    Clin Chem Lab Med; 2013 Jul; 51(7):1467-76. PubMed ID: 23241603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Separation and biochemical characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, T-active glycoproteins and N antigen precursor glycoproteins from ascites of primary ovarian cancer patients.
    Hayashi S; Ohyama K; Yanagi K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S
    Int J Biochem; 1990; 22(11):1315-24. PubMed ID: 2257955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Detection of secretory immunoglobulin A (S-IgA) and secretory component (SC) in cystic fluids from ovarian tumors and ovarian cysts].
    Briese V; Brock J; Straube W
    Arch Geschwulstforsch; 1985; 55(3):197-202. PubMed ID: 3927868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lectin binding patterns in diffuse large cell lymphoma.
    Ree HJ; Raine L; Crowley JP
    Cancer; 1983 Dec; 52(11):2089-99. PubMed ID: 6194878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Some chemical and serological properties of perchloric acid-soluble glycoproteins separated from ascitic fluid of a patient with metastatic omentum tumor from ovarian cancer].
    Kurihara M; Shimauchi S; Ohyama K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S
    Yakugaku Zasshi; 1990 Oct; 110(10):783-7. PubMed ID: 1963638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thomsen-Friedenreich (T)-active glycoproteins, blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with T activity from ascitic fluids of liver cancer patients.
    Otsuka K; Nishida S; Yuasa H; Hara A; Shirai T; Ohkuma S
    Int J Biochem; 1991; 23(9):827-37. PubMed ID: 1663465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses.
    Lu D; Davila RM; Pinto KR; Lu DW
    Diagn Cytopathol; 2004 May; 30(5):320-4. PubMed ID: 15108229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor markers in inclusion cysts of the ovary.
    Blaustein A; Kaganowicz A; Wells J
    Cancer; 1982 Feb; 49(4):722-6. PubMed ID: 7034921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
    Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
    J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
    Lapertosa G
    Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of galactose-containing glycoconjugates in the human retina: a lectin histochemical study.
    Kivelä T
    Curr Eye Res; 1990 Dec; 9(12):1195-209. PubMed ID: 2091899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purification and characterization of a peanut-agglutinin-binding pancreatic-cancer-related serum mucus glycoprotein.
    Ching CK; Rhodes JM
    Int J Cancer; 1990 Jun; 45(6):1022-7. PubMed ID: 2351483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serous ovarian cyst fluids contain high levels of endometrial placental protein 14.
    Riittinen L
    Tumour Biol; 1992; 13(3):175-9. PubMed ID: 1626182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
    de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
    Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic potential of tumor DNA from ovarian cyst fluid.
    Wang Y; Sundfeldt K; Mateoiu C; Shih IeM; Kurman RJ; Schaefer J; Silliman N; Kinde I; Springer S; Foote M; Kristjansdottir B; James N; Kinzler KW; Papadopoulos N; Diaz LA; Vogelstein B
    Elife; 2016 Jul; 5():. PubMed ID: 27421040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of a novel Tn (GalNAc alpha 1-->Ser/Thr) glycoprotein with Gal, GalNAc and GlcNAc specific lectins.
    Wu AM; Wu JH; Shen F
    Biochem Biophys Res Commun; 1994 Jan; 198(1):251-6. PubMed ID: 8292029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.